Progesterone, Serum
Progesterone is a steroid hormone mainly produced in the cells of the corpus luteum of the ovary and during pregnancy in the placenta. In addition, it is also produced in small amounts by the adrenal cortex in men and women, and the testes in men.
Progesterone, in conjunction with estrogens, regulates reproductive tract functions during the menstrual cycle. Progesterone is critical in preparing the endometrium for blastocyst implantation and the maintenance of pregnancy. Progesterone levels are low during the follicular phase of the menstrual cycle. After ovulation, progesterone production by the corpus luteum increases rapidly, reaching a maximum concentration 4 to 7 days after ovulation. These levels are maintained for 4 to 6 days then fall to baseline levels, inducing menstruation. During pregnancy, progesterone levels rise steadily to their highest levels in the third trimester. Furthermore, during pregnancy, progesterone inhibits the contraction of the myometrium. In the mammary gland, progesterone (together with estrogens) promotes the proliferation and secretion of protein in the alveoli.
Clinical evaluation of progesterone confirms ovulation and normal luteal function in nonpregnant women. Inadequate progesterone production by the corpus luteum may indicate luteal phase deficiency (LPD), which is associated with infertility and early miscarriage. Also, the determination of progesterone is utilized in fertility diagnosis for the detection of ovulation and assessment of the luteal phase. Women using oral contraceptives have suppressed progesterone levels.
- Pregnancy evaluation and monitoring of placental function
- Fertility diagnosis and treatment monitoring
- Detection of ovulation and assessment of the luteal phase during the menstrual cycle
- Differentiation of normal intrauterine from abnormal intrauterine or ectopic pregnancy (with other hormones such as HCG)
- Evaluation of infertility
- Monitoring in vitro fertilization and ovulation
- Other related pregnancy complications
- Part of the evaluation of some adrenal and testicular tumors
Increased in:
- During pregnancy
- In ectopic pregnancy (but significantly lower then normal pregnancy)
- In vitro fertilization
- Congenital adrenal hyperplasia due to 21- hydroxylase, 17α-hydroxylase and 11β-hydroxylase deficiency
- Lipoid ovarian tumors
- Theca lutein cyst
- Molar pregnancy
- Chorioepithelioma of ovary
Decreased in:
- Contraceptive agents use
- Some other drugs
- Threatened abortion
- Primary or secondary hypogonadism
- Short lutel phase syndrome
Serum Reference Ranges
Units: ng/dL / nmol/L
| Group | ng/dL | nmol/L |
| Cord blood | 8,000–56,000 | 254–1780 |
| Premature | 84–1360 | 2.7–43.2 |
| Prepubertal child (1–10 yr) | 7–52 | 0.2–1.7 |
| Puberty (by Tanner Stage) | ||
| Stage 1 – Male | 10–33 | 0.3–1.0 |
| Stage 1 – Female | 10–33 | 0.3–1.0 |
| Stage 2 – Male | 10–33 | 0.3–1.0 |
| Stage 2 – Female | 10–55 | 0.3–1.7 |
| Stage 3 – Male | 10–48 | 0.3–1.5 |
| Stage 3 – Female | 10–450 | 0.3–14.3 |
| Stage 4 – Male | 10–108 | 0.3–30.2 |
| Stage 4 – Female | 10–1300 | 0.3–41.3 |
| Stage 5 – Male | 21–82 | 0.7–2.6 |
| Stage 5 – Female | 10–950 | 0.3–30.2 |
| Adult Females | ||
| Follicular phase | 15–70 | 0.5–2.2 |
| Luteal phase | 200–2500 | 6.4–79.5 |
| Pregnancy | ||
| First trimester | 1025–4400 | 32.6–139.9 |
| Second trimester | 1950–8250 | 62.0–262.4 |
| Third trimester | 6500–22,900 | 206.7–728.2 |
| Adult Male | 13–97 | 0.4–3.1 |
Urine Reference Values
Units: mg/g creatinine / µmol/mol creatinine
| Group | mg/g | µmol/mol |
| Male | 0.12 + 0.10 | 0.04 + 0.04 |
| Female | Follicular: 1.4 + 1.1 | 0.50 + 0.39 |
| Luteal: 7.7 + 4.6 | 2.76 + 1.65 |
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Serum gel (SST) preferred, Serum Red top acceptable. Urine collected in a sterile urine cup or tube.
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- J Clin Invest. 1984;73:1638−47. [PMID: 6427277]
- Rev Fr Gynecol Obstet. 1991 Oct;86(10):563-5. [PMID: 1763263]
- Fertil Steril. 1982;37(3):348−54. [PMID: 7060785]
- Chattoraj SC, Watts NB. Endocrinology. In: Tietz NW, editor. Fundamentals of Clinical Chemistry. Philadelphia: WB Saunders (1987). Page 575.
- ''Practical evaluation of hormonal status,'' in Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, edited by SSC Yen and RB Jaffe. Philadelphia, WB Saunders Company (1978). Page 493
- Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757